Company Filing History:
Years Active: 2020-2023
Title: Mark E O'Malley: Innovator in Genetic Treatments
Introduction
Mark E O'Malley is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of genetic treatments, particularly in addressing autosomal recessive congenital ichthyosis. With a total of 2 patents, O'Malley's work is paving the way for advancements in medical therapies.
Latest Patents
O'Malley's latest patents focus on compositions and methods for the treatment of autosomal recessive congenital ichthyosis. The disclosures provide recombinant nucleic acids that comprise one or more polynucleotides encoding a transglutaminase (TGM) polypeptide, specifically a Transglutaminase-1 (TGM1) polypeptide. These patents also include viruses that comprise the recombinant nucleic acids, as well as methods of their use and articles of manufacture or kits thereof.
Career Highlights
Mark E O'Malley is currently associated with Krystal Biotech, Inc., where he continues to innovate in the field of genetic therapies. His work is instrumental in developing new treatment options for patients suffering from genetic skin disorders.
Collaborations
O'Malley collaborates with talented professionals such as Suma Krishnan and Pooja Agarwal, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Mark E O'Malley's contributions to genetic treatments highlight his role as a leading inventor in the medical field. His patents and ongoing work at Krystal Biotech, Inc. are set to make a significant impact on the treatment of genetic disorders.